Adagio Medical Holdings, Inc. (ADGM) Stock

Adagio Medical Holdings, Inc. (ADGM) is a Healthcare stock trading at $0.70 (as of 2026-06-18), with a market capitalization of $15.37M and a trailing P/E of -0.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Adagio Medical Holdings, Inc. is a medical device company developing and commercializing ablation technologies for cardiac arrhythmias. Its product portfolio includes cryoablation and pulsed-field cryoablation catheters and accessories for conditions such as atrial fibrillation, atrial flutter, and ventricular tachycardia, serving clinicians treating these arrhythmias.

Valuation — source: SEC EDGAR (first-party)
Price$0.70
Market Cap$15.37M
P/E Ratio-0.5
EV / EBITDA-1.4
Price / Book2.72
DCF Value (model)$-15.04
DCF Upside vs Price-2257.2%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$0.00
Return on Equity-425.6%
Debt / Equity4.00
Current Ratio1.85
Revenue Growth (YoY)-100.0%
EPS Growth (YoY)-38.0%
FCF Growth (YoY)-45.3%
Financial Health — source: SEC EDGAR
Altman Z-Score-4.13 (distress)
Valuation vs Sector & Industry
Stock P/E-0.5
Sector P/E (Healthcare)20.9
Industry P/E (Medical Equipment)31.7
vs Sector-102.6%
vs Industry-101.7%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderPERCEPTIVE ADVISORS LLC ($11.01M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryMedical Equipment
CEOTodd Usen
Employees80
CountryUS
IPO Date2024-07-23

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Myomo, Inc. (MYO)
  • electroCore, Inc. (ECOR)
  • Harvard Bioscience, Inc. (HBIO)
  • Retractable Technologies, Inc. (RVP)
  • Milestone Scientific Inc. (MLSS)
  • IRIDEX Corporation (IRIX)
  • Bionano Genomics, Inc. (BNGO)
  • Sintx Technologies, Inc. (SINT)
ADGM earnings history · ADGM institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.